Drug discovery in the late twentieth and early twenty-first century has witnessed a myriad of changes that were adopted to predict whether a compound is likely to be successful, or conversely enable identification of molecules with liabilities as early as possible. These changes include integration of in silico strategies for lead design and optimization that perform complementary roles to that of the traditional in vitro and in vivo approaches. The in silico models are facilitated by the availability of large datasets associated with high-throughput screening, bioinformatics algorithms to mine and annotate the data from a target perspective, and chemoinformatics methods to integrate chemistry methods into lead design process. This chapter highlights the applications of some of these methods and their limitations. We hope this serves as an introduction to in silico drug discovery. © 2012 Springer Science+Business Media New York.
CITATION STYLE
Sacan, A., Ekins, S., & Kortagere, S. (2012). Applications and limitations of in silico models in drug discovery. Methods in Molecular Biology. https://doi.org/10.1007/978-1-61779-965-5_6
Mendeley helps you to discover research relevant for your work.